Exchanging knowledge for wealth.

NexOptic Initiates Development of Telephoto Imaging System for Mobile Devices

NexOptic Technology Corp. (OTCQB: NXOPF) (TSX VENTURE: NXO) (FRANKFURT: E301) (BERLIN: E301) and Spectrum Optix Inc. of Calgary, Canada announces they have initiated an engineering trade study to examine the application of a new design for Spectrum’s technology in certain mobile devices, including smartphones. The engineering trade study is the first step towards the development of a prototy…

Shackling of the Press

Your freedom to say what you want, and for the media to report truthfully, is under attack in America. If certain politicians have their way, your ability to freely criticize the government could be curtailed. Sure, there’s fake news, but let’s not forget about freedom of speech. Here’s a look at the shackling of the press.…

What Happened to NexOptic Technology Corp?

Last week, we witnessed a roller coaster ride in one of our largest holdings, NexOptic Technology (NXO). Here’s the scoop on what happened, as we explain the tactics of how big money firms short stocks. But don’t tell anyone, it’s supposed to be a secret……

Brexit Still in Play: Another Look at What is to Come

Lost in the political firestorm of Donald Trump’s RussiaGate hearings comes the news that Queen Elizabeth gave her Royal Assent to the Brexit bill. Great Britain is now free to jump off the cliff created by the Brexit referendum last year, and Prime Minister Theresa May plans to take that jump on March 29. Here’s what could happen.…

3D Signatures’ TeloView™ Software Identifies and Stages Patients With Alzheimer’s Disease From a Cheek Swab

3D Signatures Inc. announces clinical study results which confirm that based on a swab from the inside of a patient’s cheek, its proprietary TeloView™ software platform has the ability to identify patients with Alzheimer’s disease (“AD”) and, furthermore, distinguish between mild, moderate, and severe forms of the disease. The results of this confirmatory study have been accepted for publication i…